However, Dusp18 inhibition did impair tumor growth and prolonged survival in immunocompetent mice (Fig. 1h-j) although depleting CD8+ T cells completely eliminated this growth disadvantage (Fig. 1k–m and Supplementary Fig. 1n). This evidence concerns the gene CD8A and neoplasm.